Interleukin-11 drives early lung inflammation during mycobacterium tuberculosis infection in genetically susceptible mice

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Kapina, Marina A ^a   Shepelkova, Galina S ^a   Avdeenko, Vadim G ^a   Guseva, Anna N ^a   Kondratieva, Tatiana K ^a   Evstifeev, Vladimir V ^a   Apt, Alexander S ^a  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; RECOMBINANT INTERLEUKIN 11; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL INFILTRATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOBLOTTING; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PNEUMONIA; POSITIVE FEEDBACK; PROTEIN EXPRESSION; TH1 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOLOGY;

MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTIBODIES; AUTOCRINE COMMUNICATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INTERLEUKIN-11; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA; TRANSCRIPTION, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 79960338586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021878     Document Type: Article

References (34)

1. Du X, Williams DA, (1997) Interleukine-11: review of molecular, cell biology, and clinical use. Blood 89: 3897-3908.
2. Taga T, Kishimoto T, (1997) GP 130 and the interleukine-6 family of cytokines. Ann Rev Immunol 15: 797-819.
3. Sims NA, Walsh NC, (2010) GP 130 cytokines and bone remodeling in health and disease. BMB Reports 43: 513-523.
4. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ, (1996) Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 157: 3627-3634.
5. Peterson RL, Wang L, Albert L, Keuth JC Jr, Dorner AJ, (1998) Molecular effects of recombinant human interleukine-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest 78: 1503-1512.
6. Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, et al. (2006) Randomized, double-blind, controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease. Am J Gastroenterol 101: 793-797.
7. Bosani M, Ardizzione S, Porro GB, (2009) Biological targeting in the treatment of inflammatory bowel disease. Biologics: Targets & Therapy 3: 77-97.
8. Wang PK, Campbell IK, Robb L, Wicks IP, (2005) Endogenous IL-11 is pro-inflammatory in acute methylated bovine serum albumin/IL-1-induced (mBSA/IL-1) arthritis. Cytokine 29: 72-76.
9. Trepicchio WL, Ozawa M, Walters IB, Kikuchi T, Gilleaudeau P, et al. (1999) Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 104: 1527-1537.
10. Feinglass S, Deodhar A, (2001) Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11. Arthritis Rheum 44: 70-75.
11. Zheng T, Nathanson MH, Elias JA, (1994) Histamine augments cytokine-stimulated IL-11 production by human lung fibriblasts. J Immunol 153: 4742-4752.
12. Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, et al. (1994) IL-1 and TGF-beta regulation of fibroblast-derived IL-11. J Immunol 152: 2421-2429.
13. Einarsson O, Geba GP, Zhu Z, Elias JA, (1996) Interleukin-11: stimulation in vivo and in virtro by respiratory viruses and induction of airways hyper-responsiveness. J Clin Invest 97: 915-924.
14. Bartz H, Buning-Pfaue F, Turkel O, Schauer U, (2002) Respiratory virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen-presenting cells. Clin Exp Immunol 129: 438-445.
15. Wang J, Homer RJ, Hong L, Cohn L, Lee CG, et al. (2000) IL-11 selectively inhibits aerallergen-induced pulmonary eosinophilia and Th2 cytokine production. J Immunol 163: 2222-2231.
16. Kuhn CH III, Homer RJ, Zhu Z, Ward N, Flavell RA, et al. (2000) Airway hyperresponsiveness and airway obstruction in transgenic mice. Am J Respir Care Mol Med 22: 289-295.
17. Lee CC, Hartl D, Matsuura H, Dunlop FM, Scotney PD, et al. (2008) Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am J Respir Cell Mol Biol 39: 739-746.
18. Orlova MO, Majorov KB, Lyadova IV, Eruslanov EB, M'lan CE, et al. (2006) Constitutive differences in gene expression profiles parallel genetic patterns of susceptibility to tuberculosis in mice. Infect Immun 74: 3668-3672.
19. Lyadova IV, Tsiganov EN, Kapina MA, Shepelkova GS, Sosunov VV, et al. (2010) In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs. PLoS One 4: e10469.
20. Nikonenko BV, Averbakh MM, Lavebratt C, Schurr E, Apt AS, (2000) Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. Tuber Lung Dis 80: 15-25.
21. Ulrichs T, Kosmiadi GA, Jorg S, Pradl L, Titukhina M, et al. (2005) Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J Infect Dis 192: 89-97.
22. Lenaerts AJ, Hoff D, Aly S, Ehlers S, Andries K, et al. (2007) Mycobacteria in a guinea pig model of tuberculosis revealed by r207910. Antimicrob Agents Chemother 51: 3338-3345.
23. Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, et al. (2005) Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 73: 1744-1753.
24. Kondratieva EV, Logunova N, Majorov KB, Averbakh MM, Apt AS, (2010) Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium. PLoS One 5: e10515.
25. Keller C, Hoffmann R, Lang R, Brandau S, Hermann C, et al. (2006) Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 74: 4295-4309.
26. Beisiegel M, Kursar M, Koch M, Loddenkemper C, Kuhlmann S, et al. (2009) Combination of host susceptibility and virulence of Mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation. J Infect Dis 199: 1222-1232.
27. Bozza M, Bliss JL, Dorner AJ, Trepicchio WL, (2001) Interleukine-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J Interferon Cytokine Res 21: 21-30.
28. Torroella-Kouri M, Keith JC, Ivanova M, Lopez DM, (2003) IL-11-induced reduction of C/EBR transcription factor binding may contribute to the IL-12 down-regulation in tumor-bearung mice. Int J Oncol 22: 439-448.
29. Russell D, (2007) Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5: 39-47.
30. Nickonenko BV, Apt AS, Moroz AM, Averbakh MM, (1985) Genetic analysis of susceptibility of mice to H37Rv tuberculosis infection: sensitivity versus relative resistance. Progr Leuk Biol 3: 291-299.
31. Eruslanov EB, Majorov KB, Orlova MO, Mischenko VV, Kondratieva TK, et al. (2004) Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clin Exp Immunol 135: 19-28.
32. Glatman-Freedman A, Casadevall A, (1998) Serum therapy for tuberculosis revisited: reapprisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev 11: 514-532.
33. Pfeiffer NE, Wylier DE, Schuster SM, (1987) Immunoaffinity chromatography utilizing monoclonal antibodies. Factors which influence antigen-binding capacity. J Immunol Meth 97: 1-9.
34. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.